Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen
Objective(s): An efficient vaccine against TB is an urgent need. TB peptides are safe candidate but they are weak immunogens and needs to be potentiated by adjuvant/delivery systems. The main purpose of the present study was to determine the potential of CHT based NPs containing ESAT-6 antigen of M....
Main Authors: | Seyedeh Mahnaz Karimi, Mojtaba Sankian, Farzad Khademi, Mohsen Tafaghodi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2016-10-01
|
Series: | Nanomedicine Journal |
Subjects: | |
Online Access: | http://nmj.mums.ac.ir/article_7577_a285cb2779cfa2ba6628bb04532ae349.pdf |
Similar Items
-
In vivo evaluation of mucoadhesive properties of nanoliposomal formulations upon coating with trimethylchitosan polymer
by: Bahman Khameneh, et al.
Published: (2014-04-01) -
Mechanical properties of N,N,N-trimethylchitosan chloride films
by: Douglas de Britto, et al.
Published: (2005-06-01) -
Preliminary characterization of N-trimethylchitosan as a nanocarrier for malaria vaccine
by: P.O. Nnamani , G. Scoles & S. Kröl
Published: (2011-12-01) -
The role of ESAT-6 in tuberculosis immunopathology
by: Beatriz B. S. Passos, et al.
Published: (2024-04-01) -
Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan–Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy
by: Chen Fu, et al.
Published: (2022-06-01)